Sarah Howell

Sarah Howell

Chief Executive Officer at ARECOR THERAPEUTICS PLC

Net worth: 2 M $ as of 30/05/2024

49 year
Health Technology
Consumer Services

Profile

Sarah Jennifer Howell is currently the Chief Executive Officer & Director at Arecor Ltd.
since 2015.
She is also the Chief Executive Officer & Executive Director at Arecor Therapeutics Plc since 2021.
Previously, she worked as the Director-Outsourced Manufacturing & Biologics at UCB SA, as a Team Leader at GSK Plc, and as the VP-Chemistry, Manufacturing & Controls at BTG Ltd.
Dr. Howell completed her undergraduate degree at the University of Birmingham and holds a doctorate degree from the University of St. Andrews.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
15/11/2022 867,738 ( 2.83% ) 2 M $ 30/05/2024

Sarah Howell active positions

CompaniesPositionStart
ARECOR THERAPEUTICS PLC Chief Executive Officer 12/04/2021
Chief Executive Officer 31/12/2014
All active positions of Sarah Howell

Former positions of Sarah Howell

CompaniesPositionEnd
UCB Corporate Officer/Principal -
GSK PLC Corporate Officer/Principal -
BTG Corporate Officer/Principal -
See the detail of Sarah Howell's experience

Training of Sarah Howell

University of St. Andrews Doctorate Degree
University of Birmingham Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Sarah Howell's experience

Connections

19

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
UCB

Health Technology

GSK PLC

Health Technology

ARECOR THERAPEUTICS PLC

Health Technology

Private companies2

Health Technology

Health Technology

See company connections
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW